Alaunos Therapeutics, Inc. (TCRT)
NASDAQ: TCRT · IEX Real-Time Price · USD
1.090
+0.040 (3.81%)
May 31, 2024, 4:00 PM EDT - Market closed

Alaunos Therapeutics Stock Forecast

Stock Price Forecast

There is currently no analyst price target forecast available for TCRT.

Analyst Consensus: Hold
Target Low Average Median High
Price n/a n/a n/a n/a
Change n/a n/a n/a n/a

Analyst Ratings

The average analyst rating for TCRT stock from 2 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating Dec '23Jan '24Feb '24Mar '24Apr '24May '24
Strong Buy 000000
Buy 222220
Hold 222222
Sell 000000
Strong Sell 000000
Total 444442

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
HC Wainwright & Co.
HC Wainwright & Co.
Hold
Downgrades
n/a
Hold Downgrades n/a n/a Aug 16, 2023
Laidlaw & Co.
Laidlaw & Co.
Hold
Downgrades
n/a
Hold Downgrades n/a n/a Aug 15, 2023
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Upgrades
$23
Strong Buy Upgrades $23 +1,964.22% May 15, 2023
Wells Fargo
Wells Fargo
Buy
Initiates
$45
Buy Initiates $45 +4,028.44% Mar 27, 2023
Wells Fargo
Wells Fargo
Buy
Initiates
$45
Buy Initiates $45 +4,028.44% Oct 4, 2022
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
from 5.00K
Revenue Next Year
568.06M
EPS This Year
-0.61
from -2.20
EPS Next Year
0.88
from -0.61
Year 20192020202120222023202420252026
Revenue
--398.00K2.92M5.00K-568.06M-
Revenue Growth
---634.17%-99.83%---
EPS
-10.50-5.70-5.55-2.61-2.20-0.610.88-0.14
EPS Growth
--------
No. Analysts -----343
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 202420252026
High n/a 584.8M n/a
Avg n/a 568.1M n/a
Low n/a 545.8M n/a

Revenue Growth

Revenue Growth 202420252026
High - - -
Avg - - -
Low - - -

EPS Forecast

EPS 202420252026
High -0.63 0.90 -0.15
Avg -0.61 0.88 -0.14
Low -0.59 0.84 -0.14

EPS Growth

EPS Growth 202420252026
High - - -
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.